Safety and Effectiveness of Lower Alteplase Dose Driven by Impending Clinical Deterioration Factors in very Elderly Submassive Pulmonary Embolism Patients. Case Series. acmcr [Internet]. 2022 Oct. 5 [cited 2026 Sep. 11];6(5):669-78. Available from: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22671